XML 26 R18.htm IDEA: XBRL DOCUMENT v3.22.1
PUBLIC OFFERING AND PRIVATE PLACEMENT (Tables)
3 Months Ended
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]  
Schedule of Derivative Liabilities at Fair Value
The fair value of the warrants has been estimated with the following weighted-average assumptions, including the most sensitive input, volatility:
March 31, 2022December 31, 2021
Risk-free interest rate
2.40%1.22%
Volatility
92.00%94.00%
Expected term (years)
4.384.64
The following table reflects the fair value roll forward reconciliation of the warrant derivative liabilities for the period ended March 31, 2022:
(in thousands)Warrant Derivative Liability
Balance, December 31, 2021
$2,773 
Change in fair value1,637 
Balance, March 31, 2022
$4,410 
Summary of Warrants Outstanding and Exercisable
A summary of warrants outstanding and exercisable as of March 31, 2022 is as follows:

Year IssuedWarrants Outstanding and ExercisableWeighted Average Remaining
Contractual Life
Weighted Average Exercise Price
(in years)(per share)
20195,750,0004.39$13.00 
20204,149,3783.59$6.50 
202011,659,752$— 
20212,055,9206.69$1.69 
2021220,559,210$— 
34,174,260